Ossium Health

San Francisco, United States Founded: 2016 • Age: 10 yrs
Ossium Health is focused on bioengineering for improved health.

About Ossium Health

Ossium Health is a Healthcare company based in San Francisco (United States) founded in 2016 by Kevin Caldwell and Erik Woods. Ossium Health is focused on bioengineering for improved health. It operates on a HealthTech and Professional Services model. Ossium Health has raised $125.41 million across 12 funding rounds from investors including HHS, Computer Programs Marketing Group and Vivo Capital. Its chief executive, as recorded, is Kevin Caldwell. Ossium Health offers products and services including Stem Cell Therapy, Organ Transplant Solutions, and Orthopedic Treatments. Its focus areas include Biotechnology and Cell Therapy. Its legal entity is Ossium Health, Inc. Its competitors include Cellino, Adicet Bio and Orca Bio; 3 of its 3 listed competitors have raised funding.

Company details

Ossium Health is engaged in bioengineering to enhance human health, vitality, and longevity. The company is recognized for creating a new paradigm in cell therapy by utilizing deceased donor transplant ecosystems to combat blood and immune system diseases. Solutions are developed for hematologic diseases, organ transplant rejection, and orthopedic applications. Partnerships are established with healthcare providers, life science companies, and organ procurement organizations to advance and deploy innovative cell therapies.

  • Headquarters San Francisco, United States
  • Founders Kevin Caldwell, Erik Woods
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website ossiumhealth.com
  • Social LinkedIn X
  • Legal Name Ossium Health, Inc.
Operational Areas
Key Metrics
  • Total Equity Funding
    $125.41M (USD)

    in 12 rounds

  • Latest Funding Round
    $375.11K (USD), Grant

    Aug 2024

  • Investors
    HHS

    & 8 more

Products & Services of Ossium Health

Ossium Health offers a comprehensive portfolio of products and services, including Stem Cell Therapy, Organ Transplant Solutions, and Orthopedic Treatments.

Stem Cell Therapy
Cell Therapy

Stem cells are developed for blood disease treatment.

Organ Transplant Solutions
Medical Solutions

Solutions are provided to prevent organ transplant rejection.

Orthopedic Treatments
Medical Treatments

Treatments are offered for orthopedic health and recovery.

Funding Insights of Ossium Health

Ossium Health has successfully raised a total of $125.41M across 12 strategic funding rounds. The most recent funding activity was a Grant round of $375.11 thousand completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $125.41M
  • Total Rounds 12
  • Last Round Grant β€” $375,113
  • Investors Count 9

Latest 10 of 12 funding rounds of Ossium Health with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2024$375,113Grant––
Jul 2023$52MSeries C–CPMG
Apr 2023$3.46MGrant––
–
Sep 2021$361,553Grant––
Mar 2021$63MSeries B–General Catalyst, Vivo Capital
Aug 2020$299,998Grant––
Jul 2020$299,950Grant––
May 2018$10.41MSeries A––
–
Mar 2018$1.68MGrant––
Jul 2017$239,080Grant––
Valuation history

9 investors in total: 8 institutional and 1 angel.

Investors in Ossium Health

Ossium Health has secured backing from 9 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include HHS, Computer Programs Marketing Group and Vivo Capital.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Venture capital and private equity firm
vivocapital.comPalo Alto, United States
US focused seed and early-stage VC firm
firstround.comSan Francisco, United States
Early-stage ventures are targeted for investment by this VC fund.
mantaray.vcLondon, United Kingdom
Venture capital investing and portfolio management services for accredited investors.
av.vc
Investment and transformation services for entrepreneurs in technology and finance sectors.
generalcatalyst.com
Investments in early-stage companies are managed by XYZ Venture Capital.
xyz.vcSan Francisco, United States
Public health and human services are overseen by HHS.
1953hhs.gov
Software solutions for mainframe platforms are provided by the company.
1993cpmg.comMontague, United States

Asahi Kasei

unknown_0f49936f6341465f8
Premium access

Investor details for Ossium Health

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Ossium Health

40 people are tracked at Ossium Health (12 in leadership, 28 in team).

NameRoleGroup
Kevin Caldwell
Co-Founder & CEOLeadership
Erik Woods
Co-Founder & CSOLeadership
Brian Johnstone
VP of ResearchLeadership
W. Scott Goebel
Medical DirectorLeadership
Sagar Munjal
Chief Medical Officer & SVPLeadership
Nick Niehaus
Senior Director, Accounting (controller)Leadership
Kelsey Musall
Director, Clinical ProductionLeadership
Wa'el Al Rawashdeh
Director, DevelopmentLeadership
Chip Walker-Wilson
VP of LegalLeadership
Ed Jun
Vice President FinanceLeadership
Brian Legg
Facility DirectorLeadership
Aubrey Sherry
Director, Quality AssuranceLeadership
Melany Magrone
Manager, Donor ServicesTeam
Michael Blue
Senior Material HandlerTeam
Kevin Blankenberger
Quality Control Associate III & CLIA General SupervisorTeam
Kerry Gray
Cell Therapy Associate II, Clinical ProductionTeam
Nick Weinstein
Floor Supervisor, Clinical ProductionTeam
Elisa Hartman
Cell Therapy Associate II, Clinical ProductionTeam
Tyler Hoodlebrink
Cell Therapy Associate II, Clinical ProductionTeam
Winston Woodfork
Cell Therapy Associate II, Clinical ProductionTeam

20 more people are available in the full profile.

Premium access

Complete people profiles for Ossium Health

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Ossium Health

3 dated milestones of Ossium Health across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded Ossium Health is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Grant, of $375K.

Competitors of Ossium Health

Ossium Health has 3 listed competitors in our database, 3 of them funded. They include Cellino, Adicet Bio and Orca Bio.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
cellinobio.com2017Cambridge, United States$125M63
Developer of autologous cell therapies
adicetbio.com2014Menlo Park, United States$51M86
Immune cell therapies for cancer treatment are developed.
orcabio.com2016Menlo Park, United States$300M66
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders
Premium access

Detailed competitors of Ossium Health

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Ossium Health

The website of Ossium Health (ossiumhealth.com) receives about 7.5K visits a month.

  • Monthly visits
    7.5K

    ▲ 129.5% vs previous month

Similar websites

Websites whose visitors overlap most with Ossium Health. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
r2mpharma.com
100%
2.9K#4,331,217View details
quantatx.com
100%
3.1K#5,909,422View details
astellasgenetherapies.com
99%
1KView details
excision.bio
97%
2.4K#7,581,873View details
aligos.com
97%
3.4K#3,982,602View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 34 similar websites and full traffic analytics for Ossium Health

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 34 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Cell Therapy

3 companies that operate in the same segment as Ossium Health (Cell Therapy) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
2013Seattle, Washington, United StatesUSD 316.67 M520
CAR-T and TIL immunotherapies for solid tumors are developed.
2018San Francisco, California, United StatesUSD 493 MUSD 36 K233
Smart surgical devices for spinal surgery are developed.
1997San Diego, California, United StatesUSD 54.1 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Ossium Health

Premium access

Complete news archive for Ossium Health

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ossium Health

Ossium Health was founded in 2016.

Ossium Health is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

Kevin Caldwell is the CEO of Ossium Health, as recorded in our data. They have also founded this company.

Ossium Health is a funded company, having raised a total of $125.41M across 12 funding rounds to date. The company's 1st funding round was a Grant of $239.08K, raised on Aug 2016.

Ossium Health is engaged in bioengineering to enhance human health, vitality, and longevity. The company is recognized for creating a new paradigm in cell therapy by utilizing deceased donor transplant ecosystems to combat blood and immune system diseases. Solutions are developed for hematologic diseases, organ transplant rejection, and orthopedic applications. Partnerships are established with healthcare providers, life science companies, and organ procurement organizations to advance and deploy innovative cell therapies.

Ossium Health's top competitors include Orca Bio, Cellino and Adicet Bio.

Ossium Health offers Stem Cell Therapy, Organ Transplant Solutions, and Orthopedic Treatments.

Ossium Health has 9 investors. Key investors include HHS, Computer Programs Marketing Group, Vivo Capital, First Round Capital, and Manta Ray.

Ossium Health operates through Ossium Health, Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available